Zoetis Inc. (ZTS)
Makes medicines, vaccines, and diagnostics for pets and farm animals.
$76.92+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-47.8%
The outlook
Zoetis trades near the lower end of its 52-week range and below its key moving averages, reflecting weak near-term momentum. Analysts broadly favor the stock with a Buy consensus, and their average price target sits about 48% above the current price. The company's low trailing P/E of 12.6 suggests modest valuation, though current technicals remain subdued.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 17 analysts
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +48% vs current price
Analyst price target
~12-month · 17 analysts$113.82average target+48.0% vs now
Now $76.92
Low $80.00High $160.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$160.48
52-wk low
$71.47
50-day avg
$77.14
200-day avg
$111.77
Trailing P/E
12.6